STEP-1 trial (Wilding et al., New England Journal of Medicine, 2021) primary clinical trial for semaglutide 2.4 mg (Wegovy), source for the cross-drug diarrhea-rate comparison
For consumers who are concerned about companies policies on animal testing, Skin Deep reports this information
Your healthcare provider may recommend diagnostic evaluation, including upper endoscopy (esophagogastroduodenoscopy) if you have alarm symptoms, refractory GERD despite optimized therapy, or risk factors for Barrett's esophagus (such as chronic GERD plus male sex, age over 50, White race, central obesity, tobacco history, or family history)
The bigger issue is that the product may not be what the label says
Convenience We understand that life can be hectic, which is why we go the extra mile to ensure accessing quality care is as convenient as possible